Cutaneous T cell lymphoma

Reinhard Dummer(University of Zurich), Egle Ramelyte(University of Zurich), Connor J. Stonesifer(Columbia University), Pietro Quaglino(Department of Medical Sciences), Julia Scarisbrick(NIHR Surgical Reconstruction and Microbiology Research Centre), Maarten H. Vermeer(Leiden University Medical Center), Larisa J. Geskin(University of Pittsburgh), Younha Kim(Stanford University), Cornelis P. Tensen(Leiden University Medical Center)
Nature Reviews Disease Primers
August 26, 2021
10.1038/s41572-021-00296-9
Cited by 170

Related Papers

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
|Nature|2010|1.4k
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
|Blood|2007|1.4k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996